{
    "organizations": [],
    "uuid": "ca278a1354aebf2ef735601e317beda1b8774fdf",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-inovio-pharmaceuticals-q1-loss-per/brief-inovio-pharmaceuticals-q1-loss-per-share-0-36-idUSASC0A14C",
    "ord_in_thread": 0,
    "title": "BRIEF-Inovio Pharmaceuticals Q1 Loss Per Share $0.36",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9 (Reuters) - Inovio Pharmaceuticals Inc:\n* INOVIO PHARMACEUTICALS REPORTS 2018 FIRST QUARTER FINANCIAL RESULTS\n* Q1 LOSS PER SHARE $0.36 * Q1 EARNINGS PER SHARE VIEW $-0.11 â€” THOMSON REUTERS I/B/E/S\n* TOTAL REVENUE WAS $1.5 MILLION FOR THREE MONTHS ENDED MARCH 31, 2018, COMPARED TO $10.4 MILLION FOR SAME PERIOD IN 2017 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-10T04:27:00.000+03:00",
    "crawled": "2018-05-10T17:32:07.018+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "inovio",
        "pharmaceutical",
        "inc",
        "inovio",
        "pharmaceutical",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "q1",
        "loss",
        "per",
        "share",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "total",
        "revenue",
        "million",
        "three",
        "month",
        "ended",
        "march",
        "compared",
        "million",
        "period",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}